These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19067667)

  • 21. Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction.
    DeFilippis EM; Singh A; Divakaran S; Gupta A; Collins BL; Biery D; Qamar A; Fatima A; Ramsis M; Pipilas D; Rajabi R; Eng M; Hainer J; Klein J; Januzzi JL; Nasir K; Di Carli MF; Bhatt DL; Blankstein R
    J Am Coll Cardiol; 2018 Jun; 71(22):2540-2551. PubMed ID: 29535062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparities in liver transplantation before and after introduction of the MELD score.
    Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
    JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore.
    Lee YM; Fernandez M; Da Costa M; Lee KH; Sutedja DS; Tai BC; Tan KC; Isaac J; Prabhakaran K; Lim SG
    Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in Tobacco Product Use Among Past Month Adult Marijuana Users and Nonusers: Findings From the 2003-2012 National Survey on Drug Use and Health.
    Schauer GL; Berg CJ; Kegler MC; Donovan DM; Windle M
    Nicotine Tob Res; 2016 Mar; 18(3):281-8. PubMed ID: 26009578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
    Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
    World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving graft survival for patients undergoing liver transplantation.
    Dickson RC; Pungpapong S; Keaveny AP; Taner CB; Ghabril M; Aranda-Michel J; Satyanarayana R; Bonatti H; Kramer DJ; Nguyen JH
    Clin Transplant; 2011; 25(3):E345-55. PubMed ID: 21429010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction.
    Mukamal KJ; Maclure M; Muller JE; Mittleman MA
    Am Heart J; 2008 Mar; 155(3):465-70. PubMed ID: 18294478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of the OPTN/UNOS Liver Transplant Registry.
    Waki K; Tamura S; Sugawara Y; Yamashiki N; Kadowaki T; Kokudo N
    Clin Transpl; 2009; ():55-64. PubMed ID: 20524276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of lung transplantation from donors with a history of substance abuse.
    Donahoe LL; Cypel M; de Perrot M; Yeung J; Wang S; Pierre A; Waddell TK; Yasufuku K; Keshavjee S
    J Thorac Cardiovasc Surg; 2023 Jan; 165(1):384-395.e4. PubMed ID: 36216597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions.
    Fleming JN; Taber DJ; Pilch NA; Mardis CR; Gilbert RE; Wilson LZ; Patel N; Ball S; Mauldin P; Baliga PK
    J Am Coll Surg; 2018 Apr; 226(4):651-659. PubMed ID: 29309943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of smoking on survival for patients with end-stage liver disease.
    Lee DS; Mathur AK; Acker WB; Al-Holou SN; Ehrlichman LK; Lewin SA; Nguyen CK; Peterson SF; Ranney DN; Sell K; Kubus J; Englesbe MJ
    J Am Coll Surg; 2009 Jun; 208(6):1077-84. PubMed ID: 19476895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Arterial Conduit is Not a Risk Factor for Survival Following Orthotopic Liver Transplantation: An Analysis of 20 Years of Liver Transplantation in Innsbruck.
    Denecke C; Weiss S; Biebl M; Fritz J; Dziodzio T; Aigner F; Sucher R; Brandl A; Bösmüller C; Pratschke J; Öllinger R
    Ann Transplant; 2016 May; 21():321-8. PubMed ID: 27215293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.
    Hu Z; Zhou J; Li Z; Xiang J; Zhang Q; Yan S; Wu J; Zhang M; Wang W; Zheng S
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):206-216. PubMed ID: 28107613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly-drug and marijuana use among adults who primarily used methamphetamine.
    Herbeck DM; Brecht ML; Lovinger K; Raihan A; Christou D; Sheaff P
    J Psychoactive Drugs; 2013; 45(2):132-40. PubMed ID: 23909001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recipient characteristics and morbidity and mortality after liver transplantation.
    Asrani SK; Saracino G; O'Leary JG; Gonzalez S; Kim PT; McKenna GJ; Klintmalm G; Trotter J
    J Hepatol; 2018 Jul; 69(1):43-50. PubMed ID: 29454069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
    Kulik LM; Fisher RA; Rodrigo DR; Brown RS; Freise CE; Shaked A; Everhart JE; Everson GT; Hong JC; Hayashi PH; Berg CL; Lok AS;
    Am J Transplant; 2012 Nov; 12(11):2997-3007. PubMed ID: 22994906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-Transplantation Immune Cell Distribution and Early Post-Transplant Fungal Infection Are the Main Risk Factors of Liver Transplantation Recipients in Lower Model of End-Stage Liver Disease.
    Abdelhamid NM; Chen YC; Wang YC; Cheng CH; Wu TJ; Lee CF; Wu TH; Chou HS; Chan KM; Lee WC; Soong RS
    Transplant Proc; 2017; 49(1):92-97. PubMed ID: 28104167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.